首页>
外国专利>
Acylamido-methyl penicillin and cephalosporin esters - for oral administration and subsequent in-tissue enzymic hydrolysis to parent antibiotic
Acylamido-methyl penicillin and cephalosporin esters - for oral administration and subsequent in-tissue enzymic hydrolysis to parent antibiotic
展开▼
机译:酰胺基甲基青霉素和头孢菌素酯-口服给药及随后的组织内酶水解为母体抗生素
展开▼
页面导航
摘要
著录项
相似文献
摘要
Penicillins and cephalosporins of the formula (I) and their acids addn. salts are novel:- (where A-B = R and R1 are each H or (1-4C) alkyl; R2 (up to 10C) straight or branched alkyl substd. by 1 to 3 halogen or R1 and R2 together = -(CH2)n-; n = 2 to 5; R3 = H or methoxy; R4 = benzyl, thienyl-(2)-methyl, furyl-(2)- methyl, phenoxymethyl, 1-phenoxyethyl, 1-phenoxypropyl, alpha-phenoxybenzyl, 2,6-dimethoxyphenyl, (alpha-carboxy ester) benzyl, 1-(opt. substd. amino)benzyl or (nuclear hydroxy, amino or fluoro mono-substd. benzyl), 3-phenyl-5-methyl-isoxazolyl-(4) (or derivs thereof mono- or di-hydroxy, amino, chloro, fluoro substd. on the phenyl group), cyclohexa-1,4-dienyl-aminomethyl, 1-aminocyclohexyl-(1), 2-ethoxynaphthyl-(1), 2-carboxyquinoxalinyl-(3) or 1,2,3,4-tetrazolyl-1-methyl; R5 = H or acetoxy). (I) are antibacterial agents which are tasteless and may be administered orally whereas the parent antibiotic may have to be given parenterally. (I) are hydrolysed by enzymes in the tissues to give the parent antibiotic in situ. M.I.C. against Staphylococcus aureus for dicloxacillin dichloracetamidomethyl ester was 0.015 ug/ml.
展开▼